Rescuing the malfunctioning cardiomyocytes in myocardial patients: Hyperoside (quercetin 3-D-galactoside) improves myocardial function after myocardial infarction via up regulation of PNUTS/PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10), 22/April/2014, 9.10 am

Molecular therapy for Human Cancer: Deltex1 suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) via up regulation of its target gene, 22/April/2015, 9.03 am
April 22, 2015
Insight into the treatment of Metastatic Pancreatic/intestine/ovarian Cancers: Tumor suppressor p73alpha suppresses the expression of PDGF Receptor β (PDGFRβ) through interaction with histone deacetylase NF-Y, 22/April/2014, 13.45
April 22, 2015
Show all

A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published in the 7 March  2013 issue of Nature  by Prof Dimmler, Boon, and others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Rescuing the malfunctioning cardiomyocytes in myocardial patients: Hyperoside improves myocardial function after myocardial infarction via  up regulation of PNUTS/PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10)

Significance: 

This study suggests, for the first time, that Hyperoside, by increasing the expression of its target gene, it may increase the expression of PNUTS/PPP1R10. Thereby, it may: (1) inhibit DNA damage responses, (2) inhibit telomere shortening; and (3) promote cardimyocyte survival/regeneration. Therefore, Hyperoside may prevent ageing-associated decline in cardiac function. Together, pharmacological formulations encompassing “Hyperoside or its analogues” may be used to improve cardiac function after myocardial infarction

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Rescuing the malfunctioning cardiomyocytes in myocardial patients: Hyperoside (quercetin 3-D-galactoside) improves myocardial function after myocardial infarction via  up regulation of PNUTS/PPP1R10 (Serine/threonine-protein phosphatase 1 regulatory subunit 10), 22/April/2014,  9.10 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Undisclosed information: How Hyperoside increases the expression of PNUTS/PPP1R10

Comments are closed.